Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

View:
Post by C10H12N2 on Dec 28, 2022 7:36pm

@ stocktwits

@Snelgrok Thank you for some of your positive acknowledgement of my due diligence here. However, I believe you are completely off base with stating I'm potentially on some personal attack of Algernon Pharmaceuticals. Sir, Algernon is writing their story with the actions they're talking as a publicly traded company. It's ALL up for scrutiny! They need to go private if they don't want to be held publicly accountable for their actions and/or inactions - failures to act. Without a retraction and apology to shareholders and the public at large in Canada & USA, I believe it shows an arrogance and unwillingness to admit fault that will continue to be untoward at best for anyone who aligns their investment ambitions with Algernon Pharmaceuticals business activities.

Be the first to comment on this post